THE GOOD, THE BAD AND THE UGLY OF TRANSFORMING TO AGILE TEAMS

Please listen to our first Agile Teams webinar! We welcomed Andrew Chandler and Nancy Stern to share their first-hand experiences transforming Genentech’s delivery of breakthrough therapies from large, slower-moving teams to much smaller, network-centric agile teams. They discussed the paramount importance of mindset, their high-level transformation methodology, and where Genentech is in its journey. With candor, they shared what had gone well and the surprises about what had gone wrong.

Read more about Connected Commons agile teams research, including Genentech’s case study, in the Networks for Agility white paper, soon to be published in Harvard Business Review.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Their transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

Connected Commons, co-managed by i4cp, is an open community of business, organizational and academic leaders who believe that in an interdependent world, networks are quickly becoming the organizing paradigm of our social and organizational lives. It is committed to improving the performance and well-being of individuals, organizations and society by pioneering research-based applications of Organization Network Analysis in the areas of Talent Optimization, Innovation & Agility, and Personal Leadership.